A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.

NCT05686759 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

BIOLOGICAL: Undiluted I.V.-Hepabig inj(GC5103)
BIOLOGICAL: Diluted I.V.-Hepabig inj(GC5103)

Sponsor

GC Biopharma Corp